WHY IT MATTERS: Patients purchasing hemp-derived products in Alabama and other states with limited oversight may be unknowingly consuming products with inaccurate THC levels or harmful contaminants, which poses real risks to health and undermines therapeutic goals. CLINICAL OVERVIEW: Unregulated hemp-derived products have long occupied a legal gray zone where labeling claims frequently diverge from actual contents, and third-party testing has repeatedly revealed discrepancies in cannabinoid concentrations alongside contamination with mold, pesticides, and carcinogenic compounds. Alabama’s new THC limits for hemp products reflect a broader regulatory trend of states stepping in to fill the vacuum left by federal inaction on consumer safety standards for this category.
Many Hemp Intoxicants Contain THC, Synthetic Cannabinoids – NORML
WHY IT MATTERS: If you are currently using commercially available hemp-derived intoxicants such as delta-8 or delta-10 products, you may be consuming synthetic cannabinoids or illegal THC levels without any labeling disclosure to warn you. CLINICAL OVERVIEW: Unregulated intoxicating hemp products pose a serious public health concern because many contain delta-9 THC concentrations above the federal 0.3% legal threshold, effectively making them unregistered cannabis products sold without the consumer protections of a licensed dispensary system. More alarming is the presence of synthetic cannabinoids in a significant proportion of these products, compounds with unpredictable pharmacology, narrow safety margins, and no established therapeutic dosing data.